_version_ 1785085116475768832
author Naik, Sachin
Pal, Deeksha
Shukla, Shubham
Kumar, Vinod
Kumar, Ashwini
Jha, Vivekanand
Minz, Ranjana
Sethi, Jasmine
Bharati, Joyita
Divyaveer, Smita
Kumar, Vivek
Rathi, Manish
Kohli, Harbir Singh
Ramachandran, Raja
author_facet Naik, Sachin
Pal, Deeksha
Shukla, Shubham
Kumar, Vinod
Kumar, Ashwini
Jha, Vivekanand
Minz, Ranjana
Sethi, Jasmine
Bharati, Joyita
Divyaveer, Smita
Kumar, Vivek
Rathi, Manish
Kohli, Harbir Singh
Ramachandran, Raja
author_sort Naik, Sachin
collection PubMed
description
format Online
Article
Text
id pubmed-10403650
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104036502023-08-06 Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk Naik, Sachin Pal, Deeksha Shukla, Shubham Kumar, Vinod Kumar, Ashwini Jha, Vivekanand Minz, Ranjana Sethi, Jasmine Bharati, Joyita Divyaveer, Smita Kumar, Vivek Rathi, Manish Kohli, Harbir Singh Ramachandran, Raja Kidney Int Rep Research Letter Elsevier 2023-05-16 /pmc/articles/PMC10403650/ /pubmed/37547518 http://dx.doi.org/10.1016/j.ekir.2023.05.009 Text en © 2023 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Naik, Sachin
Pal, Deeksha
Shukla, Shubham
Kumar, Vinod
Kumar, Ashwini
Jha, Vivekanand
Minz, Ranjana
Sethi, Jasmine
Bharati, Joyita
Divyaveer, Smita
Kumar, Vivek
Rathi, Manish
Kohli, Harbir Singh
Ramachandran, Raja
Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
title Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
title_full Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
title_fullStr Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
title_full_unstemmed Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
title_short Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
title_sort rituximab in patients with primary membranous nephropathy with high immunologic risk
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403650/
https://www.ncbi.nlm.nih.gov/pubmed/37547518
http://dx.doi.org/10.1016/j.ekir.2023.05.009
work_keys_str_mv AT naiksachin rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT paldeeksha rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT shuklashubham rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT kumarvinod rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT kumarashwini rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT jhavivekanand rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT minzranjana rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT sethijasmine rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT bharatijoyita rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT divyaveersmita rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT kumarvivek rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT rathimanish rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT kohliharbirsingh rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk
AT ramachandranraja rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk